HDAC9 and atherosclerosis: Furthermore, both class IIa HDAC inhibition and genetic Hdac9 knockout reversed phenotypic endothelial cell changes that were induced by EndMT and led to favorable changes in atherosclerotic plaques, suggesting potential therapeutic benefit in the treatment of atherosclerosis.